NXERA PHARMA UK LIMITED (06267989) is a private limited company registered in CAMBRIDGE, incorporated in 2007. The company operates in the research and experimental development on biotechnology sector. Our database holds 28 signals from 12 official sources covering this company's filings, appointments, and regulatory records. Risk assessment: 87/100 ("robust"), reflecting a strong compliance and financial profile.
NXERA PHARMA UK LIMITED is an active private limited company incorporated in 2007 in Cambridge, engaged in research and experimental development on biotechnology.
Standard data coverage across 12 sources. Risk score of 87 indicates a strong compliance profile.
NXERA PHARMA UK LIMITED is 1 of 295 research and experimental development on biotechnology companies in CAMBRIDGE, out of 4,024 active companies in this sector nationally (4,909 including dissolved).
NXERA PHARMA UK LIMITED is listed as the proprietor of 3 properties in the HM Land Registry.
Properties are located in East Anglia.
This company profile is built from 10 official data sources: Ch Officers, Companies House, Environment Agency, GLEIF, Gateway to Research, HM Land Registry, HMRC Trade Info, ICO, Modern Slavery Registry, Uk Trade Info.
NXERA PHARMA UK LIMITED is an active private limited company incorporated in 2007 in Cambridge, engaged in research and experimental development on biotechnology..
Current directors include MR CHRISTOPHER ROBERT CARGILL, MR KIERAN ROY DARREN JOHNSON, MISS MARIKO NAKAFUJI and 2 more.
NXERA PHARMA UK LIMITED is registered in CAMBRIDGE, United Kingdom.
NXERA PHARMA UK LIMITED operates under SIC code 72110 — Research and experimental development on biotechnology.
NXERA PHARMA UK LIMITED has a risk score of 87 out of 100, classified as "Robust". This score is calculated from 28 data signals across 12 government sources.
The next accounts for NXERA PHARMA UK LIMITED are due on 30 Sept 2027.
Yes, NXERA PHARMA UK LIMITED was previously known as HEPTARES THERAPEUTICS LIMITED.
Yes, NXERA PHARMA UK LIMITED is listed as the proprietor of 3 properties in the HM Land Registry, located in East Anglia.
The dissolution rate for the research and experimental development on biotechnology sector in the UK is 12.2%. The average company age in this sector is 7.2 years.
NXERA PHARMA UK LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
NXERA PHARMA UK LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
NXERA PHARMA UK LIMITED was incorporated on 4 Jun 2007, making it 19 years old. The company remains active and in good standing.
NXERA PHARMA UK LIMITED is classified under SIC code 72110 (Research and experimental development on biotechnology). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 28 data signals from 12 official government sources for NXERA PHARMA UK LIMITED.